Responses
Inflammatory bowel disease
PTH-090 Efficacy and Safety of Double-Dosing or Decreasing the Interval of Anti-Tnf Therapy in Crohn’S Disease who have Shown Loss of Response to Standard Anti-Tnf Dosing Regimen - A Dgh Experience
Compose a Response to This Article
Other responses
No responses have been published for this article.